ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 770,95
0,00%
Dow Jones
44 025,81
1,24%
DAX
21 041,52
0,00%
Brent Oil
78,385
-0,46%
Bitcoin
104 969,14
-1,13%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Akoya BioSciences Inc (AKYA) Cours

Akoya BioSciences Inc

Akoya BioSciences Inc (AKYA)

NASDAQ
3,02
0,20
(7,09%)
Fermé 22 Janvier 10:00PM
Retardé de 15 minutes
3,09
0,07
(2,32%)
Après les heures de négociation: 1:58AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
3,09
Prix Achat
2,95
Prix Vente
3,09
Volume échangé
802 177
2,755 Fourchette du Jour 3,05
1,88 Plage de 52 semaines 6,31
Cap du marché
153,151M
Clôture Veille
2,82
Ouverture
2,79
Dernière Transaction
730
@
3.09
(formt)
Dernière heure de transaction
Volume financier
US$ 2 399 082
VWAP
2,9907
Volume moyen (3 m)
632 608
Actions en circulation
49 563 386
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,37
Bénéfice par action (BPA)
-1,28
Chiffre d'affairess
96,63M
Bénéfice net
-63,32M

À propos de Akoya BioSciences Inc

Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clini... Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. Show more

Secteur
Lab Analytical Instruments
Industrie
Lab Analytical Instruments
Site Web
www.akoyabio.com
Siège social
Dover, Delaware, USA
Fondé
-
Akoya BioSciences Inc est coté dans le secteur Lab Analytical Instruments de la NASDAQ avec le ticker AKYA. Le dernier cours de clôture d'Akoya BioSciences était de US$2,82. Au cours de la dernière année, les actions de Akoya BioSciences ont été négociées dans une fourchette de prix de US$ 1,88 à US$ 6,31.

Akoya BioSciences compte actuellement 49 563 386 actions en circulation. La capitalisation boursière d'Akoya BioSciences est de US$139,77 million. Akoya BioSciences a un ratio cours/bénéfice (ratio PE) de -2.37.

AKYA Dernières nouvelles

Plus de nouvelles

Form 425 - Prospectuses and communications, business combinations

16 Janvier 2025
Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations

15 Janvier 2025
Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations

10 Janvier 2025
Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations

10 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

10 Janvier 2025
Edgar (US Regulatory)

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

Complementary offerings will accelerate translation of biomarkers from research to the clinic driving new growth Expanded customer relationships and continuum of solution offerings maximize...

10 Janvier 2025
Business Wire

Form 8-K - Current report

13 Décembre 2024
Edgar (US Regulatory)

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

MARLBOROUGH, Mass. and FRANKFURT, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company, and NeraCare, a leading developer of laboratory...

10 Décembre 2024
GlobeNewswire Inc.

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

MARLBOROUGH, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, announced that Nature Methods, one of the world’s leading...

09 Décembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

21 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.082.657807308973.013.12.594334952.71930469CS
40.7431.48936170212.353.422.2614777732.98038708CS
120.238.041958041962.863.421.99016326082.79558661CS
260.7129.83193277312.383.421.93639992.75090171CS
52-1.97-38.93280632415.066.311.883139643.03031511CS
156-8.65-73.679727427611.7416.571.881994035.651757CS
260-22.91-88.11538461542628.941.881921067.54378175CS

AKYA - Frequently Asked Questions (FAQ)

What is the current Akoya BioSciences share price?
The current share price of Akoya BioSciences is US$ 3,09
How many Akoya BioSciences shares are in issue?
Akoya BioSciences has 49 563 386 shares in issue
What is the market cap of Akoya BioSciences?
The market capitalisation of Akoya BioSciences is USD 139,77M
What is the 1 year trading range for Akoya BioSciences share price?
Akoya BioSciences has traded in the range of US$ 1,88 to US$ 6,31 during the past year
What is the PE ratio of Akoya BioSciences?
The price to earnings ratio of Akoya BioSciences is -2,37
What is the cash to sales ratio of Akoya BioSciences?
The cash to sales ratio of Akoya BioSciences is 1,55
What is the reporting currency for Akoya BioSciences?
Akoya BioSciences reports financial results in USD
What is the latest annual turnover for Akoya BioSciences?
The latest annual turnover of Akoya BioSciences is USD 96,63M
What is the latest annual profit for Akoya BioSciences?
The latest annual profit of Akoya BioSciences is USD -63,32M
What is the registered address of Akoya BioSciences?
The registered address for Akoya BioSciences is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Akoya BioSciences website address?
The website address for Akoya BioSciences is www.akoyabio.com
Which industry sector does Akoya BioSciences operate in?
Akoya BioSciences operates in the LAB ANALYTICAL INSTRUMENTS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
263,47M
DWTXDogwood Therapeutics Inc
US$ 3,18
(70,05%)
24,31M
USEGUS Energy Corp
US$ 3,74
(61,21%)
107,79M
DOGZDogness International Corporation
US$ 27,62
(52,60%)
1,95M
MYNAMynaric AG
US$ 0,6697
(50,83%)
3,72M
GOEVCanoo Inc
US$ 0,3748
(-72,24%)
41,46M
SHOTWSafety Shot Inc
US$ 0,1094
(-47,40%)
18,66k
ORKTOrangeKloud Technology Inc
US$ 0,7068
(-36,89%)
7,67M
HEPAHepion Pharmaceuticals Inc
US$ 0,3219
(-31,36%)
1,66M
WNWMeiwu Technology Company Ltd
US$ 0,2681
(-27,05%)
11,12M
GCTKGlucoTrack Inc
US$ 0,1226
(44,41%)
613,28M
CRKNCrown Electrokinetics Corporation
US$ 0,1121
(-10,32%)
392,52M
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
262,98M
RIMEAlgorhythm Holdings Inc
US$ 0,034599
(-16,83%)
230,08M
RGTIRigetti Computing Inc
US$ 13,97
(42,12%)
226,81M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
AKYA
Akoya BioSciences
EU
FR2CIBFS5739
Credit Agricole CIB FCIA...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés